Moody’s assigns ‘Baa2’ rating to Boston Medical Center’s bonds

Moody’s Investors Service has assigned a “Baa2” rating to Boston Medical Center’s proposed $75 million of series 2016 taxable bonds.

Advertisement

The rating assignment is based on a number of factors, including BMC’s key role as a healthcare provider in the Boston metro area and provider of heath insurance through an affiliated health insurance plan.

These strengths are offset by several challenges, including a payer mix heavily weighted toward governmental payers and BMC’s reliance on supplemental funding for cash flow.

The outlook is stable, reflecting Moody’s Investors Service’s view that BMC will continue to receive supplemental funding and generate adequate margins.

Moody’s has also affirmed its “Baa2” rating on BMC’s $421 million of outstanding debt.

More articles on healthcare finance:
4 quotes from Carolinas CEO Michael Tarwater on hospital consolidation and prices
Rural hospital turns to mill levy for much-needed revenue
Less than 7% of healthcare spending comes from “shoppable” services

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-MetrixPaul Summers, Nevada Heart & Vascular

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.